PLUS THERAPEUTICS, Inc. (PSTV) Social Stream

Featured Post From StockTwits About PSTV

$PSTV The U.S. Food and Drug Administration has granted both Orphan Drug designation and Fast Track designation to RNL™ for the treatment of patients with GBM. Additional details about the ReSPECT™ trial are available at clinicaltrials.gov (NCT01906385).